Formulary Search Results for: CALCIUM AND VITAMIN D
3.1.2 Antimuscarinic bronchodilators - View Category
Restrictions:
For use as a maintenance bronchodilator in COPD. Preferred List use of tiotropium only relates to use in COPD.
Prescribing Notes:
Preferred brand and device:
- Tiogiva®
To prevent confusion, prescribe inhaler devices by brand name.
5.1.10 Antileprotic drugs - View Category
Restrictions:
Restricted to specialist initiation.
Prescribing Notes:
For indications in dermatology please refer to section 13.10.1.2
5.1.12 Quinolones - View Category
Restrictions:
Restricted to use on the advice of a consultant microbiologist or consultant infectious disease physician for patients with acute bacterial skin and skin structure infections (ABSSSI) who have suspected or confirmed polymicrobial infection following treatment failure or when standard antibacterial therapies are not suitable.
Please note: this is a PROTECTED ANTIBIOTIC (see policy here) and relevant paper work should be completed.
Prescribing Notes:
Due to the risk of severe, disabling and potentially permanent adverse events, new restrictions apply to the prescribing of fluoroquinolones.
Please see new MHRA advice (January 2024) and NHSGGC statement (March 2024) for more details.
5.3.1.5 Other HIV combination preparations - View Category
5.3.1.5 Other HIV combination preparations - View Category
5.3.1.5 Other HIV combination preparations - View Category
5.3.1.5 Other HIV combination preparations - View Category
5.3.1.5 Other HIV combination preparations - View Category
Restrictions:
The use for the treatment of HIV-1 infection in treatment naive adults, or treatment experienced adults without known mutations associated with resistance to the non-nucleoside reverse transcriptase inhibitor (NNRTI) class, tenofovir or emtricitabine, and with viral load ≤100,000 HIV-1 RNA copies/mL, is restricted to HIV specialists only.
5.3.1.5 Other HIV combination preparations - View Category
Restrictions:
Use in the treatment of HIV infection is restricted to use by HIV specialists only.
Use for the pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in at-risk men who have sex with men, including adolescents (with body weight at least 35 kg) is restricted to specialist use for those patients who have renal or bone issues for whom other alternative PrEP options are not suitable.
Prescribing Notes:
Preferred preparation for PrEP in NHSGGC is generic Emtricitabine/tenofovir disoproxil.
5.3.1.5 Other HIV combination preparations - View Category
Restrictions:
- The treatment of HIV infection is restricted to use by HIV specialists.
- Use in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults at high risk is restricted to specialist use only by consultants in sexual health and infectious disease consultants.
Prescribing Notes:
Preferred preparation for PrEP in NHSGGC.
Non-Formulary indications:
- Treatment of HIV-1 infected adolescents aged 12 to <18 years with nucleoside reverse transcriptase inhibitor resistance or toxicities precluding the use of first-line agents